Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013 | - | ||
The role of MAT1A mutation in biliary atresia disease initiation and progression: an iPSC study [Poster presentation] Proceeding/Conference:International Society for Stem Cell Research Annual Meeting 2023 (14/06/2023-17/06/2023, Boston) | 14-Jun-2023 |